- Home
- BRIA vs AVTX Comparison
BRIA vs AVTX Comparison
Compare BRIA & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- AVTX
- Stock Information
- Founded
- BRIA 2011
- AVTX 2011
- Country
- BRIA Singapore
- AVTX United States
- Employees
- BRIA N/A
- AVTX N/A
- Industry
- BRIA
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BRIA
- AVTX Health Care
- Exchange
- BRIA NYSE
- AVTX Nasdaq
- Market Cap
- BRIA 76.2M
- AVTX 88.4M
- IPO Year
- BRIA 2024
- AVTX 2015
- Fundamental
- Price
- BRIA $3.02
- AVTX $8.44
- Analyst Decision
- BRIA
- AVTX Strong Buy
- Analyst Count
- BRIA 0
- AVTX 4
- Target Price
- BRIA N/A
- AVTX $33.00
- AVG Volume (30 Days)
- BRIA 15.2K
- AVTX 37.8K
- Earning Date
- BRIA 03-04-2025
- AVTX 03-28-2025
- Dividend Yield
- BRIA N/A
- AVTX N/A
- EPS Growth
- BRIA N/A
- AVTX N/A
- EPS
- BRIA 92.24
- AVTX N/A
- Revenue
- BRIA $55,755,669.00
- AVTX $820,000.00
- Revenue This Year
- BRIA N/A
- AVTX N/A
- Revenue Next Year
- BRIA N/A
- AVTX N/A
- P/E Ratio
- BRIA $0.03
- AVTX N/A
- Revenue Growth
- BRIA 8.03
- AVTX N/A
- 52 Week Low
- BRIA $2.90
- AVTX $4.24
- 52 Week High
- BRIA $4.38
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- AVTX 57.77
- Support Level
- BRIA N/A
- AVTX $6.81
- Resistance Level
- BRIA N/A
- AVTX $8.00
- Average True Range (ATR)
- BRIA 0.00
- AVTX 0.56
- MACD
- BRIA 0.00
- AVTX 0.03
- Stochastic Oscillator
- BRIA 0.00
- AVTX 81.99
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).